“We are very excited to have found this potent neutralizing antibody that we hope will participate in ending the COVID-19 pandemic,” said project co-lead David Veesler, PhD, with the University of Washington in Seattle.
Testing all residents and staff at the nation’s nursing homes just once would collectively cost $440 million, according to data from the American Health Care Association and National Center of Assisted Living (AHCA/NCAL).
Cardiac cath labs can achieve significant radiation dose reductions through focused, collaborative quality improvement (QI) efforts, according to a new analysis published in Circulation: Cardiovascular Interventions.
The nation’s largest commercial health insurer said the update took effect last month and applies to its policyholders with low or intermediate risk of coronary artery disease.
The news came just weeks after the FDA warned against treating COVID-19 with hydroxychloroquine “outside of the hospital setting or a clinical trial” due to significant cardiovascular complications.
COVID-19 isn’t only keeping patients home when they should be seeing their doctors. It’s also keeping clinical investigators from moving ahead with their research.
